Why the Ephesus Artemis
came to be a symbol for
this survivor e-zine?

October 1998

Been Hearing About Herceptin? Here are the Facts

In late September the Food and Drug Administration gave its approval to a pioneering new drug, Herceptin, the first in what promises to be a wave of genetically-engineered treatments for breast cancer.

"It heralds a new age in how we're going to treat cancer, with better understanding -- and targeted therapies," said Dr. Dennis Slamon of the University of California, Los Angeles, whose genetic research led to Herceptin.
Read full article

Research Review

Major Trial to Compare Tamoxifen and Raloxifene

Lowering tamoxifen Doses to Reduce Side-Effects

Sentinel Node "Mapping" To Detect Cancer

Optical Biopsy Offers Fast, Painless Alternative

A Chemo Gel To Shrink Breast Tumors

Quantifying the Impact of Fatigue

How Pain Impacts Quality of Life


If you would like to be notified of updates or changes to the Johns Hopkins Breast Center Web Site or to the Center's e-zine, Artemis, just enter your e-mail address here:

[ Archived Issues / Search ]


Home
Johns Hopkins
Breast Center



Quality
Corner